If this email does not display correctly, click here

Newsletter #185
November 25th, 2021


Dear Friends,

This time, our newsletter begins with an article signed by Rene van den Wijngaard about a new pilot randomized, doubled-blind, placebo-controlled trial that suggest the potential of spore-forming probiotics in patients with functional dyspepsia. 

Next up, a new proof-of-principle study reveals that supplementing low-fermentable fiber following fecal microbiota transplantation may improve insulin sensitivity in individuals with severe obesity. You will also come across new proof-of-concept findings from INRAE suggesting that the combined targeting of host inflammation and the state of the gut microbiota could be an approach worth considering for increasing remission in patients with ulcerative colitis. 

Finally, a new study shows that fermented-food diet may increase microbiome diversity and decrease markers of inflammation. 

Happy reading! 

The GMFH publishing team

Spore-forming probiotic blend shows potential for managing functional dyspepsia in adults

The potential benefits of fecal microbiota transplantation in obesity could rely on supplementation of low-fermentable fiber

Gut microbiota and host inflammation states could pave the way for personalized treatments for ulcerative colitis remission

Fermented foods show potential in increasing gut microbial diversity and modulating immune responses

©2021 Gut Microbiota For Health
If you need further information send us an email to

You have received this e-mail because you have shown an interest in receiving news from us. If you don’t want to continue receiving information from us, please unsubscribe is edited by

Unsubscribe from this list    Update your preferences

Before printing this message, please check that is really necessary.